For instance, in Alzheimer disease (AD), researchers observed decreased NPY levels and NPY receptors in patients’ brain (cerebral cortex and hippocampus), decreased NPY levels in cerebrospinal fluid (CSF), and decreased NPY levels in peripheral plasma. This evidence concerns the gene NPY and Alzheimer disease.